They showed a uniform population of CD45−, CD56+, CD9+, CD81hi, GD2+ tumor cells with heterogeneous expression of CD57−/+ and CD58+/++; CD90 was positive in all but one tumor, whereas CD271 was partially expressed in only one tumor (Table 2). This evidence concerns the gene CD58 and neoplasm.